These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2569119)

  • 1. Use of flecainide in children.
    Till JA; Rowland E; Shinebourne EA
    Lancet; 1989 Aug; 2(8658):326. PubMed ID: 2569119
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of refractory supraventricular arrhythmias with flecainide acetate.
    Till JA; Rowland E; Shinebourne EA; Ward DE
    Arch Dis Child; 1987 Mar; 62(3):247-52. PubMed ID: 3105471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment.
    Uzun O; Babaoglu K; Sinha A; Massias S; Beattie B
    Cardiol Young; 2012 Aug; 22(4):372-80. PubMed ID: 22008551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tachycardias: considerations in childhood in the 90s].
    Gutiérrez-Larraya F; Jabón A
    An Esp Pediatr; 1993 Dec; 39(6):475-88. PubMed ID: 8166400
    [No Abstract]   [Full Text] [Related]  

  • 5. Digoxin or flecainide for prophylaxis of supraventricular tachycardia in infants?
    O'Sullivan JJ; Gardiner HM; Wren C
    J Am Coll Cardiol; 1995 Oct; 26(4):991-4. PubMed ID: 7560629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flecainide toxicity in a neonate with supraventricular tachycardia.
    Zeigler VL; Peterson J
    Heart Lung; 1991 Nov; 20(6):689-91. PubMed ID: 1960074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flecainide for supraventricular and ventricular arrhythmias in children and young adults.
    Zeigler V; Gillette PC; Ross BA; Ewing L
    Am J Cardiol; 1988 Oct; 62(10 Pt 1):818-20. PubMed ID: 3138905
    [No Abstract]   [Full Text] [Related]  

  • 8. [Role of a "bystander" concealed accessory pathway in the response to verapamil and flecainide treatment in a patient with nodal reentry tachycardia].
    Matteucci C; Busi G
    G Ital Cardiol; 1996 Apr; 26(4):419-25. PubMed ID: 8707026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dangerous recurrence of arrhythmia following withdrawal of flecainide.
    Murdoch IA; Priestley KA; Parsons JM
    Int J Cardiol; 1990 Aug; 28(2):259-60. PubMed ID: 2118487
    [No Abstract]   [Full Text] [Related]  

  • 10. Flecainide for supraventricular tachyarrhythmias.
    Med Lett Drugs Ther; 1992 Jul; 34(875):71-2. PubMed ID: 1630411
    [No Abstract]   [Full Text] [Related]  

  • 11. Neonatal flecainide toxicity following supraventricular tachycardia treatment.
    Hall CM; Ward Platt MP
    Ann Pharmacother; 2003 Sep; 37(9):1343-4. PubMed ID: 12921523
    [No Abstract]   [Full Text] [Related]  

  • 12. Flecainide for supraventricular tachycardia in children.
    Zeigler V; Gillette PC; Hammill B; Ross BA; Ewing L
    Am J Cardiol; 1988 Aug; 62(6):41D-43D. PubMed ID: 3136635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Our experience with flecainide acetate in resistant arrhythmias in children. Apropos of 35 cases].
    Denjoy I; Lucet V; Do Ngoc D; Magnier S; Casasoprana A; Coumel P
    Arch Mal Coeur Vaiss; 1991 May; 84(5):647-52. PubMed ID: 1910326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety issues in the treatment of paediatric supraventricular tachycardias.
    Pfammatter JP; Bauersfeld U
    Drug Saf; 1998 May; 18(5):345-56. PubMed ID: 9589846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atrioventricular nodal reentry tachycardia in children].
    Vislie CH; Mikkelsen RB; Hoff PI; Greve G
    Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2373-6. PubMed ID: 16998549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electrophysiological effects and clinical efficacy of flecainide in childhood patients with supraventricular reciprocating paroxysmal tachycardia].
    Musto B; D'Onofrio A; Cavallaro C; Musto A; Della Gatta O; Marsico F
    G Ital Cardiol; 1987 May; 17(5):444-9. PubMed ID: 3115857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of intravenous flecainide acetate in patients with concealed atrioventricular pathway with supraventricular tachycardia].
    Song Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec; 19(6):361-3, 397. PubMed ID: 1821351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Oct; 31(10):1227-43. PubMed ID: 9337449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flecainide: its value and danger.
    Malik R; Ellenbogen KA; Stambler BS; Wood MA
    Heart Dis Stroke; 1994; 3(2):85-9. PubMed ID: 8199770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of flecainide in the preventive treatment of tachycardia crisis of Wolff-Parkinson-White syndrome in 4 newborn infants].
    Lupoglazoff JM; Jacqz-Aigrain E; Denjoy I; Casasoprana A
    Arch Fr Pediatr; 1991 Nov; 48(9):627-9. PubMed ID: 1763931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.